Start Here
IGF-1 LR3 Administration Due to the lack of data from clinical research and the fact that IGF-1 LR3 is not an approved amino acid analog of insulin-like growth factor 1 for human use, there are no official recommendations on how and where to inject it
Chen L, Wu F, Chen X, Chen Y, Deng L, Cai Q, Wu L, Guo W, Chen M, Li Y
In February, the company successfully took legal action against Hims & Hers to prevent the company from selling unapproved, compounded versions of Wegovy and Ozempic
GLP-1- based treatments for T2DM, such as GLP-1 receptor agonists, dual and triple agonists that activate GLP-1R, GIPR, and glucagon receptors, and dipeptidyl peptidase-4 (DPP-4) inhibitors have been reviewed here
Nasca C, Bigio B, Lee FS, et al